Search Results
Nov 26, 2025, 10:50 ET Spinal Implants And Surgery Devices Market is expected to generate a revenue of USD 16.57 Billion by 2032, Globally, at 4.3% CAGR: Verified Market Research®
Global Orthobiologics Market Size By Product Type (Bone Graft Substitutes, Viscosupplements, Stem Cell Therapy, Bone Marrow Aspirate Concentrates (BMAC), Platelet-Rich Plasma (PRP)), By Application (Spinal Fusion, Trauma Repair, Osteoarthritis and Degenerative Arthritis, Soft Tissue Repair, Fracture
More news about: Verified Market Research
Nov 20, 2025, 06:59 ET Battery Passport Market worth $2.35 billion by 2035 | MarketsandMarkets™
visibility for regional battery plants. In 2024, a Canada-driven program involving OPTEL, Delphi, Norda Stelo, and the Battery Metals Association of Canada (BMAC) moved forward with an auditable ESG and GHG reporting framework tailored to domestic NMC supply chains. Simultaneously, the US National Institute of
More news about: MarketsandMarkets
Oct 30, 2025, 10:24 ET QC Kinetix Hosts Inaugural Medical Conference, Showcasing Clinical Depth and Innovation in Regenerative Orthobiologics
plasma (PRP) and the importance of platelet dosing to shockwave and laser therapies. Attendees observed a live bone marrow aspiration and concentrate (BMAC) procedure, designed to standardize every step of processing and reinjection across the national network. This real-time demonstration elevated
More news about: QC Kinetix
Oct 15, 2025, 06:10 ET Allied Pain & Spine Institute Launches OrthoGen Health, Its New Regenerative Medicine Division Serving Silicon Valley
platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and other biologic procedures—designed to stimulate the body's natural healing mechanisms and reduce the need for surgery. "Regenerative
More news about: OrthoGen Health
Sep 13, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
U.S. pivotal clinical trial of Hyalofast, a resorbable, hyaluronic acid scaffold used in conjunction with autologous bone marrow aspirate concentrate (BMAC) for cartilage repair." The press release stated that "[w]hile Hyalofast demonstrated consistent improvements in treated patients across all measures
More news about: Pomerantz LLP
Sep 08, 2025, 15:30 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
U.S. pivotal clinical trial of Hyalofast, a resorbable, hyaluronic acid scaffold used in conjunction with autologous bone marrow aspirate concentrate (BMAC) for cartilage repair." The press release stated that "[w]hile Hyalofast demonstrated consistent improvements in treated patients across all measures
More news about: Pomerantz LLP
Sep 03, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
U.S. pivotal clinical trial of Hyalofast, a resorbable, hyaluronic acid scaffold used in conjunction with autologous bone marrow aspirate concentrate (BMAC) for cartilage repair." The press release stated that "[w]hile Hyalofast demonstrated consistent improvements in treated patients across all measures
More news about: Pomerantz LLP
Aug 27, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
U.S. pivotal clinical trial of Hyalofast, a resorbable, hyaluronic acid scaffold used in conjunction with autologous bone marrow aspirate concentrate (BMAC) for cartilage repair." The press release stated that "[w]hile Hyalofast demonstrated consistent improvements in treated patients across all measures
More news about: Pomerantz LLP
Aug 22, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
U.S. pivotal clinical trial of Hyalofast, a resorbable, hyaluronic acid scaffold used in conjunction with autologous bone marrow aspirate concentrate (BMAC) for cartilage repair." The press release stated that "[w]hile Hyalofast demonstrated consistent improvements in treated patients across all measures
More news about: Pomerantz LLP
Aug 16, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
U.S. pivotal clinical trial of Hyalofast, a resorbable, hyaluronic acid scaffold used in conjunction with autologous bone marrow aspirate concentrate (BMAC) for cartilage repair." The press release stated that "[w]hile Hyalofast demonstrated consistent improvements in treated patients across all measures
More news about: Pomerantz LLP
Aug 11, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
U.S. pivotal clinical trial of Hyalofast, a resorbable, hyaluronic acid scaffold used in conjunction with autologous bone marrow aspirate concentrate (BMAC) for cartilage repair." The press release stated that "[w]hile Hyalofast demonstrated consistent improvements in treated patients across all measures
More news about: Pomerantz LLP
Aug 06, 2025, 18:40 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
U.S. pivotal clinical trial of Hyalofast, a resorbable, hyaluronic acid scaffold used in conjunction with autologous bone marrow aspirate concentrate (BMAC) for cartilage repair." The press release stated that "[w]hile Hyalofast demonstrated consistent improvements in treated patients across all measures
More news about: Pomerantz LLP
Aug 06, 2025, 10:10 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
U.S. pivotal clinical trial of Hyalofast, a resorbable, hyaluronic acid scaffold used in conjunction with autologous bone marrow aspirate concentrate (BMAC) for cartilage repair." The press release stated that "[w]hile Hyalofast demonstrated consistent improvements in treated patients across all measures
More news about: Pomerantz LLP
Jul 31, 2025, 18:45 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
U.S. pivotal clinical trial of Hyalofast, a resorbable, hyaluronic acid scaffold used in conjunction with autologous bone marrow aspirate concentrate (BMAC) for cartilage repair." The press release stated that "[w]hile Hyalofast demonstrated consistent improvements in treated patients across all measures
More news about: Pomerantz LLP
May 05, 2025, 12:30 ET Black Music Action Coalition's BMAC LIVE Accelerator Program Returns
available to the 2025 BMAC cohort. The selected interns benefit from consistent support from BMAC and Live Nation throughout their internship, ensuring that participants are properly equipped to maximize this opportunity. "We're incredibly proud of the success of the inaugural BMAC LIVE Accelerator
More news about: Live Nation Entertainment
Apr 29, 2025, 08:33 ET Schroeder MD Regenerative Orthopedics Expands with Second Location in Schaumburg
Bone Marrow Concentrate (Mesenchymal Stem Cell) TherapyPlatelet-Rich Plasma (PRP) TherapyBone Marrow Aspirate Concentrate (BMAC) InjectionsMicrofragmented Adipose Tissue (MFAT) Injections"Regenerative Therapies use the body's own cells to substantially reduce
More news about: SRO